Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
degarelix acetate (firmagon) (1 trial)
alendronic acid (fosamax) (1 trial)
dutasteride (avodart) (1 trial)
bicalutamide (casodex) (1 trial)
radium-223 (xofigo) (1 trial)
Osteoporosis (Phase 3)
Prostatic Neoplasms (Phase 4)
Trials (5 total)
Trial APIs (5 total)